Skip to main content
SpineGuard logo

SpineGuard — Investor Relations & Filings

Ticker · ALSGD ISIN · FR0011464452 LEI · 969500Z4BRXQX6CSL565 PA Manufacturing
Open in API
Filings indexed 466 across all filing types
Latest filing 2024-09-30 Regulatory Filings
Country FR France
Listing PA ALSGD

About SpineGuard

https://www.spineguard.com/

SpineGuard is a medical technology company that develops and markets the proprietary Dynamic Surgical Guidance (DSG) technology. DSG is a radiation-free, real-time sensing platform designed to make spine surgery safer. The technology is embedded in the company's PediGuard family of smart drilling instruments, which assist surgeons in the accurate placement of skeletal implants, particularly pedicle screws. By differentiating tissue types at the instrument's tip, the devices provide audible and visual feedback to help anticipate potential breaches of the vertebral wall, thereby enhancing procedural safety and accuracy. SpineGuard's primary goal is to establish DSG as a standard of care for securing and streamlining skeletal implant placement.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release announcing that SpineGuard obtained FDA clearance (510K #241895) for its new medical device, PsiFGuard, for commercial release in the United States. It details the significance of this regulatory achievement, includes quotes from management, discusses the market outlook, and provides company background. This type of announcement, focusing on a specific operational or regulatory milestone rather than periodic financial results (like 10-K or ER), is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it were about fundraising, but here it is purely operational/regulatory news. Since it is a specific, non-periodic announcement of a regulatory event (FDA clearance), and it doesn't fit the specific definitions for ER, IR, or LTR (which usually covers lawsuits), RNS serves as the most appropriate general regulatory announcement category, although it is a very specific type of news release. Given the options, RNS (Regulatory Filings - general regulatory announcements and fallback) is the best fit for a press release detailing a specific FDA clearance.
2024-09-30 English
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Interim / Quarterly Report Classification · 100% confidence The document is titled 'RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2024' (Half-Year Financial Report as of June 30, 2024). It contains a management report, financial statements, and an attestation by the CEO. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-11 French
Inside Information / News release on accounts, results
Earnings Release Classification · 100% confidence The document is titled "SpineGuard Reports its H1 2024 Financial Results" and contains detailed financial tables (Revenue, Gross Margin, Net Profit/Loss, EBITDA) for the half-year ending June 30, 2024, comparing them to H1 2023. It includes management commentary on performance and outlook, and discusses product development milestones relevant to the period. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year. Since it is a comprehensive report for a half-year period, it fits the definition of an Interim / Quarterly Report (IR). It is not merely an Earnings Release (ER) as it contains detailed tables and extensive operational commentary beyond key highlights. The document length (12,506 chars) confirms it is the report content itself, not a short announcement (RPA/RNS). H1 2024
2024-09-11 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document is titled "SpineGuard publie ses résultats du premier semestre 2024" (SpineGuard publishes its first-half 2024 results) and contains detailed financial tables comparing H1 2024 results (ending June 30, 2024) with H1 2023 results. It includes key metrics like revenue, gross margin, net loss, and EBITDA for the six-month period. This content structure—a comprehensive financial review for a period shorter than a year, including management commentary and detailed figures—is characteristic of an Interim/Quarterly Report. It is not an Earnings Release (ER) because it is comprehensive, not just highlights, and it is not an Annual Report (10-K) because it covers only six months. The document explicitly mentions the 'rapport financier semestriel 2024' (2024 half-yearly financial report) at the end, confirming its nature as an Interim Report. H1 2024
2024-09-11 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated September 3, 2024, announcing two key events for SpineGuard: obtaining EC-MDR certification and launching the Threaded PediGuard for anterior spine surgery in Europe. It details the significance of the MDR, includes quotes from management, and describes the medical application. This type of announcement, focusing on regulatory milestones and product commercialization news, is typically classified as a general regulatory announcement or news release, as it does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, CAP, M&A). Given the options, 'Regulatory Filings' (RNS) serves as the best fit for a general, non-standardized regulatory/operational update that is not a formal financial report or a specific insider transaction notice.
2024-09-03 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document announces a significant business event: SpineGuard obtaining CE-MDR certification and launching its PediGuard Threaded device for anterior spinal surgery in Europe. This type of announcement, detailing regulatory milestones, product expansion, and strategic updates, is characteristic of a press release or a general corporate announcement. It is not a formal periodic financial report (like 10-K or IR), a transcript (CT), or a specific shareholder vote result (DVA). Since it is a general corporate update that doesn't fit the highly specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), the most appropriate general category for a significant, non-financial-results-focused regulatory/business update is Regulatory Filings (RNS), which serves as a broad category for miscellaneous regulatory announcements not covered elsewhere. The document length is moderate (5799 chars), suggesting it is the full announcement, not just a brief notice of publication (RPA).
2024-09-03 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.